Intrinsic Value of S&P & Nasdaq Contact Us

BrainsWay Ltd. BWAY NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • IL • USD

SharesGrow Score
68/100
2/7 Pass
SharesGrow Intrinsic Value
$14.70
-7%
Analyst Price Target
$30.00
+89.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

BrainsWay Ltd. (BWAY) trades at a trailing P/E of 63.4, forward P/E of 81.1. Trailing earnings yield is 1.58%, forward earnings yield 1.23%. PEG 0.63 (Peter Lynch undervalued ≤1.0). Graham Number is $3.16.

Criteria proven by this page:

  • VALUE (58/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • PEG Ratio 0.63 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.58% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
  • Analyst consensus target $30.00 (+89.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 68/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
68/100
SG Score
View full scorecard →
~
VALUE
58/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
52/100
→ Income
GROWTH
100/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — BWAY

Valuation Multiples
P/E (TTM)63.4
Forward P/E81.1
PEG Ratio0.63
Forward PEG4.09
P/B Ratio7.15
P/S Ratio9.72
EV/EBITDA77.0
Per Share Data
EPS (TTM)$0.22
Forward EPS (Est.)$0.20
Book Value / Share$2.05
Revenue / Share$1.48
FCF / Share$0.46
Yields & Fair Value
Earnings Yield1.58%
Forward Earnings Yield1.23%
Dividend Yield0.00%
Graham Number$3.16
SharesGrow IV$14.70 (-7%)
Analyst Target$30.00 (+89.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -33.6 0.86 7.83 6.99 -
2017 -11.6 -0.06 6.44 7.35 -
2018 -14.3 0.76 13.28 5.63 -
2019 -9.7 -0.34 4.13 4.33 -
2020 -15.7 0.30 4.31 3.84 -
2021 -18.6 1.48 2.09 4.04 -
2022 -3.1 -0.03 0.90 1.50 -
2023 -25.6 0.37 2.58 3.38 -
2024 54.9 -0.33 2.57 3.91 -
2025 23.6 0.06 2.48 3.45 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.34 $11.52M $-2.4M -20.8%
2017 $-0.96 $11.15M $-7.05M -63.3%
2018 $-0.78 $16.4M $-6.48M -39.5%
2019 $-1.00 $23.1M $-10.33M -44.7%
2020 $-0.48 $22.06M $-5.39M -24.4%
2021 $-0.42 $29.66M $-6.46M -21.8%
2022 $-0.86 $27.18M $-13.35M -49.1%
2023 $-0.50 $31.79M $-4.2M -13.2%
2024 $0.18 $41.02M $2.92M 7.1%
2025 $0.36 $52.64M $7.69M 14.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.20 $0.16 – $0.26 $66.43M $65.62M – $67.24M 3
2027 $0.28 $0.20 – $0.39 $81.37M $79.74M – $82.98M 3
2028 $0.28 $0.27 – $0.29 $105.72M $103.2M – $108.18M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message